• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Merck (DE) (Group)

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *

 

	Start	1668-01-01 established_pre
	Industry	pharmaceutical
	Industry 2	reagents (bio/biochemical)
	Person	Kuhnert, Marcus (Merck (DE) 201408– CFO before CFO of Henkel Laundry + Home Care businss unit)
	Region	Darmstadt
	Country	Germany
	Street	250 Frankfurter Str.
	City	64293 Darmstadt
	Tel	+49-6151-72-0
		Address record changed: 2019-03-08
Basic data	Employees	I: 50,001 to 100,0 (2018-12-31)
	Currency	EUR
	Annual sales	14,836,000,000 (sales, net, consolidated (2018) 2018-12-31)
	Profit	3,396,000,000 (2018-12-31)
	Cash	2,170,000,000 (2018-12-31)
		* Document for �About Section�: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt.
		Record changed: 2019-08-07

Advertisement

More documents for Merck (DE) (Group)

• [1] Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt....
• [2] Merck KGaA. (10/18/19). "Press Release: Merck Launches Seed Fund for Startups in China". Darmstadt....
• [3] Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt....
• [4] Merck KGaA. (6/6/19). "Press Release: Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology". Darmstadt....
• [5] Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.....
• [6] Merck KGaA. (4/26/19). "Press Release: Wolfgang Büchele Re-elected Supervisory Board Chairman of Merck. Michael Fletterich Confirmed as Vice Chairman". Frankfurt a. M.....
• [7] Merck KGaA. (1/28/19). "Press Release: Boards of E. Merck KG Newly Elected. Incumbent Chairmen Re-elected". Darmstadt....
• [8] Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement"....
• [9] Merck KGaA. (11/6/18). "Press Release: Merck Debuts at First China International Import Expo". Shanghai....
• [10] Merck KGaA. (5/15/18). "Press Release: Merck Reports a Solid Start to 2018". Darmstadt....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.